Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Dohner, H. et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood 140, 1345–1377 (2022).
2. Tefferi, A. et al. Blast phase myeloproliferative neoplasm: Mayo-AGIMM study of 410 patients from two separate cohorts. Leukemia 32, 1200–1210 (2018).
3. Theocharides, A. et al. Leukemic blasts in transformed JAK2-V617F-positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation. Blood 110, 375–379 (2007).
4. Ross, J. S. et al. ALK fusions in a wide variety of tumor types respond to anti-ALK targeted therapy. Oncologist 22, 1444–1450 (2017).
5. Kaseb H., Mukkamalla S. K. R., Rajasurya V. Anaplastic Large Cell Lymphoma. StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Shiva Kumar Mukkamalla declares no relevant financial relationships with ineligible companies. Disclosure: Venkat Rajasurya declares no relevant financial relationships with ineligible companies (2024).